Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
KIMS Eyes Rs 100Cr Second Round Of PE Funding
Hyderabad-based hospital Krishna Institute of Medical Sciences (KIMS) is eyeing a second round of private equity funding to meet its ......
Healthcare
When Is It Right To Raise PE In Healthcare
All the elements seem to be in place for an explosive opportunity in India's multi-storeyed healthcare theme.The sheer market size ......
Healthcare
Asian Healthcare Fund Eyes 1st Close At $100M This Year
Asian Healthcare Fund, floated by Dabur Group chairman Anand Burman and former Dabur Pharma CEO Ajay Kumar Vij last year, ......
Healthcare
VCCircle Healthcare Summit: Looking Beyond The Obvious
India’s healthcare story is not just about large corporate and super specialty hospitals. It is a deep and multi-layered story ......
Healthcare
Cipla To Acquire Meditab For Rs 133Cr
Cipla Ltd is acquiring a small sized domestic pharma company Meditab Specialties for Rs 133.35 crore, signaling further consolidation in ......
Healthcare
TA Associates Buys 16% In Dr Lal Pathlabs For $35M
TA Associates, one of the oldest private equity firms in the world, has acquired a little more than 16% stake ......
Healthcare
Elephant Capital Buys 28% Stake In Clinical Research Firm
Elephant Capital plc, a London AIM market listed private equity firm, has invested £8 million (Rs 58 crore) in ClinTec ......
Healthcare
NSR-backed Nectar Lifesciences Eyes US, UK Foray
Nectar Lifesciences, the pharmaceutical company backed by private equity major New Silk Route, is betting big on entering the world’s ......
Healthcare
Kalpathi Investment Takes 45% Stake In Diagnostic Chain
Chennai based Primex Healthcare has raised venture funding by diluting a 45% stake to Kalpathi Investments. Primex plans to set ......
Healthcare
TA Associates Eyes Stake In Claris Life
US-based private equity major TA Associates is believed to be in initial stages of talks with Ahmedabad-based Claris Lifesciences to ......
